Phibro Animal Health
PAHC
#5087
Rank
HK$12.35 B
Marketcap
HK$304.84
Share price
-3.95%
Change (1 day)
73.19%
Change (1 year)

Revenue for Phibro Animal Health (PAHC)

Revenue in 2025 (TTM): HK$10.91 Billion

According to Phibro Animal Health 's latest financial reports the company's current revenue (TTM ) is HK$10.89 Billion. In 2024 the company made a revenue of HK$8.58 Billion an increase over the revenue in the year 2023 that were of HK$7.66 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Phibro Animal Health from 2013 to 2025

Annual revenue

Year Revenue Change
2025 (TTM) HK$10.91 B27.07%
2024 HK$8.58 B11.96%
2023 HK$7.66 B0.98%
2022 HK$7.59 B10.76%
2021 HK$6.85 B10.85%
2020 HK$6.18 B-2.34%
2019 HK$6.33 B-3.59%
2018 HK$6.57 B7.27%
2017 HK$6.12 B5.01%
2016 HK$5.83 B0.17%
2015 HK$5.82 B2.41%
2014 HK$5.68 B10.79%
2013 HK$5.13 B

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
Heska Corporation
HSKA
HK$1.98 B-81.79%๐Ÿ‡บ๐Ÿ‡ธ USA
Archer Daniels Midland (ADM)
ADM
HK$647.76 B 5,845.02%๐Ÿ‡บ๐Ÿ‡ธ USA
Zoetis
ZTS
HK$73.15 B 571.37%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
HK$462.55 B 4,145.25%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
HK$500.04 B 4,489.28%๐Ÿ‡บ๐Ÿ‡ธ USA
Kindred Biosciences
KIN
HK$61.7 M-99.43%๐Ÿ‡บ๐Ÿ‡ธ USA